 WALTHAM, Mass., May 28, 2021 GLOBE NEWSWIRE -- Minerva Neurosciences, Inc. NASDAQ: NERV, a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system CNS disorders, today announced that it will participate in the Jefferies Virtual Healthcare Conference on June 2, 2021 at 11:00 a.m. Eastern Time. 